ZBH
Zimmer Biomet Holdings Inc
88.30$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.3% | 30.3% | 12.1% | 19.0% | 21.7% | 25.0% | 20.1% | 18.2% | 20.9% | 23.1% | 17.2% | 20.6% | 20.5% | |
| 13.8% | 12.4% | 12.6% | 12.5% | 13.8% | 13.0% | 13.3% | 13.1% | 14.2% | 12.7% | 12.9% | 12.4% | 13.0% | |
| 0.9% | 1.3% | 1.5% | 1.4% | 1.3% | 1.0% | 1.0% | 1.0% | 1.3% | 1.1% | 1.2% | 1.1% | 1.2% | |
| 0.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.7% | -0.1% | -11.2% | -7.4% | -7.1% | 1.4% | -3.9% | -3.3% | 1.5% | 7.1% | -8.3% | -2.2% | -0.4% | |
| 5.6% | 3.2% | 5.2% | 7.5% | 1.5% | 4.2% | 2.5% | 3.9% | 6.4% | 6.7% | 3.6% | 5.3% | 5.5% | |
| -31.8% | -11.4% | -10.3% | -12.7% | -8.5% | -14.4% | -5.6% | -66.6% | -8.2% | -14.4% | -7.6% | -8.8% | -9.8% | |
| 2.9% | 2.6% | 2.6% | 2.5% | 2.7% | 2.4% | 2.5% | 2.3% | 2.4% | 2.1% | 2.2% | 2.1% | 2.2% | |
| -11.4% | -21.1% | -6.0% | -4.4% | -32.7% | -3.6% | -12.0% | -0.3% | 11.8% | -11.1% | -12.0% | -11.5% | -6.0% | |
| -9.4% | – | – | – | 29.3% | -5.6% | 46.4% | 10.6% | 26.2% | -26.7% | 0.0% | 1.4% | -0.5% | |
| -11.2% | -13.0% | -2.7% | -4.7% | -5.6% | -11.9% | 30.1% | 7.9% | 24.2% | -40.0% | -17.7% | -12.5% | -12.4% | |
| -1.6% | 6.4% | -1.2% | 1.4% | 8.2% | -2.2% | 45.0% | -39.8% | 36.8% | -31.2% | -8.0% | -0.7% | -1.7% | |
| 13.7% | 27.1% | 6.9% | 11.5% | 20.2% | 20.8% | 17.6% | 14.4% | 27.3% | 29.8% | 13.6% | 15.2% | 21.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.